Abstract
We report the case of a 4-week-old infant with severe Bordetella pertussis infection resulting in hemolytic anemia, thrombocytopenia, and acute renal failure leading to a diagnosis of hemolytic uremic syndrome (HUS) associated with pertussis. In addition to antibiotic and supportive therapy, he was treated with plasma transfusions based on the possibility of underlying complement defect, and he improved. The association of B. pertussis infection and HUS has previously been described in a patient with a mutation in the gene encoding complement factor H (CFH). However, whereas a genetic workup for complement regulator mutations was performed, no mutation was found in our patient. This case demonstrates the possible association between pertussis infection and HUS and highlights the need for increased vigilance for renal complications in this diagnosis. Despite negative results in this case, in-depth workup of the complement system may be important to guide treatment efforts and strategies.
References
Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073–1086
Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050
Berner R, Krause MF, Gordjani N, Zipfel PF, Boehm N, Krueger M, Brandis M, Zimmerhackl LB (2002) Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis. Pediatr Nephrol 17:190–192
McIntyre P, Wood N (2009) Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis 22:215–223
Greenberg DP, von Konig CH, Heininger U (2005) Health burden of pertussis in infants and children. Pediatr Infect Dis J 24:S39–S43
Pela I, Seracini D, Caprioli A, Castelletti F, Giammanco A (2006) Hemolytic uremic syndrome in an infant following Bordetella pertussis infection. Eur J Clin Microbiol Infect Dis 25:515–517
Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839
Heininger U (2001) Recent progress in clinical and basic pertussis research. Eur J Pediatr 160:203–213
Abramson T, Kedem H, Relman DA (2001) Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin. Infect Immun 69:2650–2658
Crowcroft NS, Pebody RG (2006) Recent developments in pertussis. Lancet 367:1926–1936
Mielcarek N, Hornquist EH, Johansson BR, Locht C, Abraham SN, Holmgren J (2001) Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell Microbiol 3:181–188
Perkins DJ, Gray MC, Hewlett EL, Vogel SN (2007) Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b/CD18 (Mac-1). Mol Microbiol 66:1003–1015
Smith AM, Guzman CA, Walker MJ (2001) The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol Rev 25:309–333
Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB, European Paediatric Study Group for HUS (2009) Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 24:687–696
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaturvedi, S., Licht, C. & Langlois, V. Hemolytic uremic syndrome caused by Bordetella pertussis infection. Pediatr Nephrol 25, 1361–1364 (2010). https://doi.org/10.1007/s00467-010-1449-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-010-1449-6